ICECURE SUPPORTS THE FIRST-EVER BREAST CANCER LIQUID NITROGEN CRYOABLATION CONFERENCE, SEPT 20-21, 2019, KAMEDA MEDICAL CENTER
Led by leading expert, Professor Eisuke Fukuma, we are proud to support the first-ever breast cancer liquid nitrogen (LN2) cryoablation conference at Kameda Medical Center. Join this must-attend event to hear the latest clinical insights and results from leading doctors using ProSenseTM. Register today to reserve your spot (limited availability). Learn More
ICECURE PLATINUM SPONSOR OF THE 20TH WORLD CONGRESS OF THE INTERNATIONAL SOCIETY OF CRYOSURGERY, SEPT 4-5, 2019.
Demonstrating our commitment to advance the treatment of cancer using cryosurgery, we are proud to be the Platinum sponsor of the 20th World Congress of the International Society of Cryosurgery: Sept 4-5, 2019, Haifa, Israel. With talks from top experts sharing their latest clinical findings using our ProSense™ system, come and visit the IceCure booth […]
IceCure Medical Announces New Category III CPT Code for Breast Cryoablation Therapy, Issued by the American Medical Association
New Category III CPT Code expected to support further adoption of minimally invasive cryoablation treatments for breast cancer. Learn more.
IceCure featured in the leading interventional oncology news outlet, Interventional News
IceCure’s landmark US clinical trial, ICE3, for nitrogen-based cryoablation of small, low-risk, early stage malignant breast tumors without subsequently removing them, featured in Interventional News. Cryoablation shows promise in treating low-risk breast cancers. “If the positive preliminary findings are maintained as the patients enrolled in the study continue to be monitored, that will serve as […]
IceCure to attend SIO, 8 June – 11 June 2019
Visit us at The Society of Interventional Oncology’s next scientific meeting, SIO 2019 (WCIO) booth #32, 8-11 June, Boston, USA to learn more about our next generation liquid-nitrogen-based cryoablation system, ProSense. Join us on Monday June 10th for our hands-on ablation workshop at 8:30-10.45am. Read more >
IceCure to attend ASBrS 20th Annual Meeting, 30 April – 5 May 2019
Visit us at the American Society of Breast Surgeons (ASBrS) 20th Annual Meeting. Join us at booth #314 to learn more about our next generation liquid-nitrogen-based cryoablation system, ProSense, and to hear more from our landmark ICE3 breast cancer trial in the US. Read more >
IceCure presents promising results from first-ever Interventional Radiology study
Data presented at the European Association of Urology showed the ProSense™ system at 1-year follow-up was safe, effective and without serious adverse events for treating small kidney tumors. Read more >
IceCure featured in the leading news education publication, Healio
The promise of cryotherapy as an alternative treatment for a specific group of [patients with] breast cancer.” Kenneth Tomkovich MD, radiologist at Princeton Radiology and director of breast imaging and interventions at CentraState Medical Center in Freehold, New Jersey discusses the positive preliminary findings of the ICE3 clinical trials. Read more >
IceCure to attend EAU 2019, 15-19 March 2019
Join us at the 34th Annual European Association of Urology Congress 2019. Look out for the Expert-Guided Poster Tour PT060 with Dr. Sagi Shprits on “Safety, feasibility and oncologic efficacy of treatment for small renal masses using an innovative liquid nitrogen-based cryogenic device.” Read more >